English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/154942
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


New (benz)imidazolopyridino tacrines as nonhepatotoxic, cholinesterase inhibitors for Alzheimer disease

AuthorsBoulebd, Houssem; Ismaili, L.; Martin, H.; Bonet, A.; Chioua, Mourad ; Marco-Contelles, José ; Belfaitah, A.
KeywordsTacrine analogs
Enzymes cholinesterase
Alzheimer’s disease
Antioxidants cholinesterase
Issue Date2017
CitationFuture Medicinal Chemistry 9: 723-729 (2017)
AbstractAim: Due to the multifactorial nature of Alzheimer's disease, there is an urgent search for new more efficient, multitarget-directed drugs. Results: This paper describes the synthesis, antioxidant and in vitro biological evaluation of ten (benz)imidazopyridino tacrines (7-16), showing less toxicity than tacrine at high doses, and potent cholinesterase inhibitory capacity, in the low micromolar range. Among them, compound 10 is a nonhepatotoxic tacrine at 1000 mM, showing moderate, but totally selective electric eel acetylcholinesterase inhibition, whereas molecule 16 is twofold less toxic than tacrine at 1000 μM, showing moderate and almost equipotent inhibition for electric eel acetylcholinesterase and equine butyrylcholinesterase. Conclusion: (Benz)imidazopyridino tacrines (7-16) have been identified as a new and promising type of tacrines for the potential treatment of Alzheimer's disease.
Publisher version (URL)http://dx.doi.org/10.4155/fmc-2017-0019
Identifiersdoi: 10.4155/fmc-2017-0019
issn: 1756-8919
e-issn: 1756-8927
Appears in Collections:(IQM) Artículos
(IQOG) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.